{"id":"imrecoxib","rwe":[{"pmid":"41560736","year":"2025","title":"Comparative efficacy and safety of imrecoxib versus celecoxib: a systematic review and meta-analysis.","finding":"","journal":"Frontiers in pharmacology","studyType":"Clinical Study"},{"pmid":"41247914","year":"2026","title":"Herbal analgesic patches versus NSAIDs in soft tissue injury management: real-world comparative effectiveness from a 35-center Chinese prospective cohort of 1378 participants.","finding":"","journal":"International journal of surgery (London, England)","studyType":"Clinical Study"},{"pmid":"40665439","year":"2025","title":"Analgesic application of a novel non-steroidal anti-inflammatory drug imrecoxib after total knee arthroplasty: a prospective randomized controlled study.","finding":"","journal":"Perioperative medicine (London, England)","studyType":"Clinical Study"},{"pmid":"40357333","year":"2025","title":"Imrecoxib attenuates osteoarthritis by modulating synovial macrophage polarization through inactivating COX-2/PGE2 signaling pathway.","finding":"","journal":"Frontiers in bioengineering and biotechnology","studyType":"Clinical Study"},{"pmid":"40301118","year":"2025","title":"Parecoxib sequential with imrecoxib for occurrence and remission of severe acute pancreatitis: a multicentre, double-blind, randomised, placebo-controlled trial.","finding":"","journal":"Gut","studyType":"Clinical Study"}],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Prostaglandin G/H synthase 2","category":"target"},{"label":"PTGS2","category":"gene"},{"label":"Active","category":"status"},{"label":"Osteoarthritis","category":"indication"},{"label":"HengRui","category":"company"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"company":"HengRui","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=IMRECOXIB","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T03:02:38.056191+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T03:02:44.035169+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=IMRECOXIB","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T03:02:44.648070+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL504535/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T03:02:45.349554+00:00"}},"allNames":["imrecoxib","BAP-909"],"offLabel":[],"synonyms":["imrecoxib","BAP-909"],"timeline":[{"date":"2011-05-20","type":"positive","source":"DrugCentral","milestone":"China Food and Drug Administration (CFDA) approval (HengRui)"}],"approvals":[{"date":"2011-05-20","orphan":false,"company":"HengRui","regulator":"China Food and Drug Administration (CFDA)"}],"ecosystem":[{"indication":"Osteoarthritis","otherDrugs":[{"name":"aceclofenac","slug":"aceclofenac","company":""},{"name":"acetylsalicylic acid","slug":"acetylsalicylic-acid","company":"Endo Pharms"},{"name":"celecoxib","slug":"celecoxib","company":"Gd Searle"},{"name":"choline magnesium trisalicylate","slug":"choline-magnesium-trisalicylate","company":""}],"globalPrevalence":655000000}],"mechanism":{"target":"Prostaglandin G/H synthase 2","targets":[{"gene":"PTGS2","source":"DrugCentral","target":"Prostaglandin G/H synthase 2","protein":"Prostaglandin G/H synthase 2"}],"modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"Imrecoxib acts as a non-selective inhibitor of prostaglandin G/H synthase 2, also known as cyclooxygenase-2 (COX-2), which is responsible for the conversion of arachidonic acid to prostaglandin H2, a key step in the production of prostaglandins involved in pain and inflammation."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/5250","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=IMRECOXIB","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=IMRECOXIB","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T13:56:24.291387","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:02:46.950505+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"celecoxib","drugSlug":"celecoxib","fdaApproval":"1998-12-31","patentExpiry":"May 27, 2036","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"diclofenac","drugSlug":"diclofenac","fdaApproval":"1988-07-28","patentExpiry":"Apr 23, 2030","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"flurbiprofen","drugSlug":"flurbiprofen","fdaApproval":"1986-12-31","genericCount":8,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"ibuprofen","drugSlug":"ibuprofen","fdaApproval":"1974-09-19","patentExpiry":"Sep 30, 2029","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"indomethacin","drugSlug":"indomethacin","fdaApproval":"1965-06-10","patentExpiry":"Apr 23, 2030","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"meclofenamic acid","drugSlug":"meclofenamic-acid","fdaApproval":"1980-06-25","relationship":"same-target"},{"drugName":"meloxicam","drugSlug":"meloxicam","fdaApproval":"2000-04-13","patentExpiry":"May 26, 2030","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"rofecoxib","drugSlug":"rofecoxib","fdaApproval":"1999-05-20","patentStatus":"Unknown","relationship":"same-target"}],"genericName":"imrecoxib","indications":{"approved":[{"name":"Osteoarthritis","source":"DrugCentral","snomedId":396275006,"regulator":"FDA","usPrevalence":null,"globalPrevalence":655000000,"prevalenceMethod":"curated","prevalenceSource":"Arthritis Res Ther, 2023 (PMID:36991481)"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"celecoxib","brandName":"celecoxib","genericName":"celecoxib","approvalYear":"1998","relationship":"same-target"},{"drugId":"diclofenac","brandName":"diclofenac","genericName":"diclofenac","approvalYear":"1988","relationship":"same-target"},{"drugId":"flurbiprofen","brandName":"flurbiprofen","genericName":"flurbiprofen","approvalYear":"1986","relationship":"same-target"},{"drugId":"ibuprofen","brandName":"ibuprofen","genericName":"ibuprofen","approvalYear":"1974","relationship":"same-target"},{"drugId":"indomethacin","brandName":"indomethacin","genericName":"indomethacin","approvalYear":"1965","relationship":"same-target"},{"drugId":"meclofenamic-acid","brandName":"meclofenamic acid","genericName":"meclofenamic acid","approvalYear":"1980","relationship":"same-target"},{"drugId":"meloxicam","brandName":"meloxicam","genericName":"meloxicam","approvalYear":"2000","relationship":"same-target"},{"drugId":"rofecoxib","brandName":"rofecoxib","genericName":"rofecoxib","approvalYear":"1999","relationship":"same-target"}],"trialDetails":[{"nctId":"NCT04400786","phase":"NA","title":"A Randomized Open-labeled Study for Comparing Methods of Using Imrecoxib to Treat AS","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2020-05-07","conditions":["Ankylosing Spondylitis","Therapeutic Agent Toxicity"],"enrollment":196,"completionDate":"2022-06-30"},{"nctId":"NCT03932006","phase":"PHASE4","title":"A Multicenter，Double-Blind and Randomized Controlled Trial of Fengshigutong Capsule in the Treatment of Ankylosing Spondylitis","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2016-06-30","conditions":["Ankylosing Spondylitis"],"enrollment":180,"completionDate":"2019-05-31"},{"nctId":"NCT02456688","phase":"PHASE1","title":"Pharmacokinetics of Imrecoxib in Subjects With Hepatic Insufficiency","status":"UNKNOWN","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2015-01","conditions":["Knee Osteoarthritis"],"enrollment":20,"completionDate":"2015-07"},{"nctId":"NCT02426060","phase":"PHASE1","title":"A Drug Drug Interaciton Study of Imrecoxib and Warfarin in Healthy Volunteers","status":"UNKNOWN","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2015-01","conditions":["Knee Osteoarthritis"],"enrollment":12,"completionDate":"2015-04"},{"nctId":"NCT01985165","phase":"PHASE4","title":"A Phase 4 Study of Imrecoxib in Treatment of Knee Osteoarthritis","status":"UNKNOWN","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2013-05","conditions":["Knee Osteoarthritis"],"enrollment":2400,"completionDate":""}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"SGW6W5758V","UMLSCUI":"C1505698","chemblId":"CHEMBL504535","ChEMBL_ID":"CHEMBL504535","DRUGBANK_ID":"DB12354","PUBCHEM_CID":"11682175","MESH_SUPPLEMENTAL_RECORD_UI":"C488833"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"","companyName":"HengRui","relationship":"Original Developer"}],"publicationCount":39,"therapeuticAreas":["Immunology"],"biosimilarFilings":[],"originalDeveloper":"HengRui","recentPublications":[{"date":"2025","pmid":"41560736","title":"Comparative efficacy and safety of imrecoxib versus celecoxib: a systematic review and meta-analysis.","journal":"Frontiers in pharmacology"},{"date":"2026 Feb 1","pmid":"41247914","title":"Herbal analgesic patches versus NSAIDs in soft tissue injury management: real-world comparative effectiveness from a 35-center Chinese prospective cohort of 1378 participants.","journal":"International journal of surgery (London, England)"},{"date":"2025 Jul 15","pmid":"40665439","title":"Analgesic application of a novel non-steroidal anti-inflammatory drug imrecoxib after total knee arthroplasty: a prospective randomized controlled study.","journal":"Perioperative medicine (London, England)"},{"date":"2025","pmid":"40357333","title":"Imrecoxib attenuates osteoarthritis by modulating synovial macrophage polarization through inactivating COX-2/PGE2 signaling pathway.","journal":"Frontiers in bioengineering and biotechnology"},{"date":"2025 Aug 7","pmid":"40301118","title":"Parecoxib sequential with imrecoxib for occurrence and remission of severe acute pancreatitis: a multicentre, double-blind, randomised, placebo-controlled trial.","journal":"Gut"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"IMRECOXIB","companyName":"HengRui","companyId":"hengrui","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"OTHER","regulator":"China Food and Drug Administration (CFDA)","status":"approved","approval_date":"2011-05-20T00:00:00.000Z","mah":"HengRui","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:02:46.950505+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}